Pacific Biosciences of California, Inc. Finite-Lived Intangible Assets, Net
Pacific Biosciences of California, Inc. (PACB) had Finite-Lived Intangible Assets, Net of $13.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Assets, Net $13.08M.
- 2026-03-31: Finite-Lived Intangible Assets, Net $14.10M.
- 2025-12-31: Finite-Lived Intangible Assets, Net $15.12M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $16.14M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2026-06-30 | $13.08M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $14.10M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $15.12M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $16.14M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $17.16M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $18.18M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $374.57M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $381.43M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $388.28M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $395.13M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $401.98M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $408.84M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $9.78M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $10.01M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $10.24M 10-Q · filed 2023-11-03 |
| 2022-09-30 | $10.29M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $10.52M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $10.75M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $10.98M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $11.21M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |